Series A Therapeutics Companies

ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.

Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.

Upkara operates as a biotechnology company that specializes in developing biopreservation technologies.

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

D2M Biotherapeutics focuses on the development of novel immunotherapeutics.

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

SpectrumAi is modernizing and democratizing access to high-quality autism treatment.

Mediar is a pre-clinical stage biotechnology company developing therapeutics for the treatment of fibrosis.

Switch Therapeutics is a biotech company that develops RNAi therapies.

Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.

PneumoWave develops a respiratory sensor and monitoring platform to assist patients with respiratory conditions in managing their health.

Belharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.

Macomics is an immuno-oncology company.

Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.

Re-Vana Therapeutics is a ocular pharmaceuticals & drug delivery company.

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

Resilience Lab is modernizing how clinicians work together to provide mental health care that’s high-quality, personalized, and accessible.

MYNDUP is a workplace mental health and wellbeing platform.